These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 7454125)
1. Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave. Haaheim LR NIPH Ann; 1980 May; 3(1):49-56. PubMed ID: 7454125 [TBL] [Abstract][Full Text] [Related]
2. Surveillance of the antibody status to current influenza strains in the Norwegian population. 1: Method of serum sampling and evaluation of the A/USSR/77 (H1N1) impact in various age groups in 1978. Haaheim LR NIPH Ann; 1979 Dec; 2(2):45-54. PubMed ID: 548838 [TBL] [Abstract][Full Text] [Related]
4. Laboratory and clinical investigation of the 1974 influenza epidemic in Nigeria. David-West TS; Cooke AR Bull World Health Organ; 1974; 51(1):103-5. PubMed ID: 4549036 [TBL] [Abstract][Full Text] [Related]
5. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains. Su WJ; Shao PL; Liu MT; Liu DP; Huang KC; Chang LY; Lu CY; Wang JR; Shih SR; Huang DT; Chi H; Huang LM Clin Infect Dis; 2010 Jul; 51(2):171-6. PubMed ID: 20528478 [TBL] [Abstract][Full Text] [Related]
6. Seroepidemiologic study on influenza A (H1N1) virus infection among school children after an "antigenic shift" from A (H3N2) to a (H1N1) in Kukuoka of southern Japan in 1978. Tokugawa K; Ueda K; Sakoh M; Yoshikawa H; Nonaka S Pediatr Infect Dis J; 1987 Aug; 6(8):761-2. PubMed ID: 3670940 [No Abstract] [Full Text] [Related]
7. Seroepidemiology of H1N1 influenza: the range of the affected population is widening. Pyhälä R; Aho K Med Biol; 1982 Dec; 60(6):328-32. PubMed ID: 7162226 [TBL] [Abstract][Full Text] [Related]
8. [Neutralizing and inhibiting activity of hemagglutination of serum antibodies after natural infection and after vaccination with influenza virus A/USSR/90/77 (H1N1) strain]. Profeta ML; Nardi G Boll Ist Sieroter Milan; 1983 May; 62(2):130-6. PubMed ID: 6626319 [TBL] [Abstract][Full Text] [Related]
9. [Influence vaccination: comparison of the effectiveness of two different vaccines]. Kuwert E; Thraenhart O; Werner J; Höher PG Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland]. Brydak L; Rudnicka H Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846 [TBL] [Abstract][Full Text] [Related]
11. Canadian influenza serosurvey prior to the 1992-1993 season. Can Commun Dis Rep; 1992 Nov; 18(22):161-6. PubMed ID: 1291010 [No Abstract] [Full Text] [Related]
12. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Waalen K; Kilander A; Dudman SG; Krogh GH; Aune T; Hungnes O Euro Surveill; 2010 Aug; 15(31):. PubMed ID: 20738992 [TBL] [Abstract][Full Text] [Related]
14. [Surveillance program set for influenza A virus (H1N1) in children in Taiyuan, China, 2005-2006]. Lan T; Wang NC; Chang YH; Peng GX; Na DY; Zhang CY; Wu LP Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Aug; 28(8):753-5. PubMed ID: 18080559 [TBL] [Abstract][Full Text] [Related]
15. [Safety of an influenza-split-vaccine in children]. Schmitt-Grohé S; Banzhoff A; Klaassen B; Zielen S Klin Padiatr; 2001; 213(6):338-42. PubMed ID: 11713714 [TBL] [Abstract][Full Text] [Related]
16. [Serologic survey of human type A influenza virus infection following 10-year periods of prevalence of H3N2 strains]. Profeta ML; De Vito D; Fasan M Boll Ist Sieroter Milan; 1979 Jan; 57(6):690-9. PubMed ID: 552822 [TBL] [Abstract][Full Text] [Related]
17. [Seroepidemiologic survey for A/PR/8/34 (H1N1) virus from Chinese residents]. Guo Y; Qi J; Wang M Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):223-5. PubMed ID: 12526320 [TBL] [Abstract][Full Text] [Related]
18. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914 [TBL] [Abstract][Full Text] [Related]
19. Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011. Waalen K; Kilander A; Dudman SG; Ramos-Ocao R; Hungnes O Euro Surveill; 2012 May; 17(19):. PubMed ID: 22607964 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children. Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]